Kieffer N, Bettaieb A, Legrand C, Coulombel L, Vainchenker W, Edelman L, Breton-Gorius J
INSERM U91/CNRS UA 607, Hôpital Henri Mondor, Créteil, France.
Biochem J. 1989 Sep 15;262(3):835-42. doi: 10.1042/bj2620835.
We have previously described a monoclonal antibody (FA6-152), obtained by immunizing mice with fetal human erythrocytes [Edelman, Vinci, Villeval, Vainchenker, Henri, Miglierina, Rouger, Reviron, Breton-Gorius, Sureau & Edelman (1986) Blood 67, 56-63]. The antibody labelled fetal, but not adult, erythrocytes and bound to both fetal and adult platelets and monocytes. In the present study we have characterized the antigen recognized by FA6-152 on human platelets and on cells of the erythroid lineage at different stages of maturation. FA6-152 precipitated a chymotrypsin-resistant 88 kDa sialoglycoprotein from both iodinated and periodate/NaB3H4-surface-labelled platelets which corresponds to glycoprotein IV, the platelet thrombospondin (TSP) receptor. After neuraminidase treatment, a shift of the apparent molecular mass from 88 kDa to 85 kDa was observed. Scatchard analysis revealed that 125I-FA6-152 bound saturably with high affinity to a single class of platelet binding sites (Kd 6.4 +/- 0.6 nM). The number of FA6-152 IgG molecules bound per platelet was 25,400 +/- 8,800 (n = 4) and did not change upon thrombin activation of platelets. At low doses of alpha-thrombin (0.025 unit), FA6-152 inhibited platelet aggregation as well as endogenous TSP binding to the platelet surface. Immunofluorescence labelling of bone-marrow cells and of cultures in vitro of burst-forming units-erythroid (BFU-E) and colony-forming units-erythroid (CFU-E) revealed that that FA6-152 antigen is a very early marker of erythroid differentiation and that its expression declines during maturation. Immunochemical identification of the FA6-152 antigen on fetal erythroblasts and fetal mature erythrocytes revealed a 78 kDa glycoprotein migrating just in front of the glycophorin A dimer. The antigen, which was absent from adult mature erythrocytes, was also detected in human erythroleukaemic (HEL) cells where FA6-152 precipitated two bands of molecular mass 85 and 88 kDa. Our data establish the existence of a previously unidentified 78 kDa erythroblast cell-surface glycoprotein whose expression is developmentally regulated during erythroid differentiation and which is immunologically related to the 88 kDa platelet TSP receptor.
我们之前曾描述过一种单克隆抗体(FA6 - 152),它是通过用人胎儿红细胞免疫小鼠获得的[埃德尔曼、文奇、维勒瓦尔、万琴克尔、亨利、米列里纳、鲁热、勒维隆、布雷顿 - 戈里厄斯、叙雷奥 & 埃德尔曼(1986年)《血液》67卷,56 - 63页]。该抗体标记胎儿红细胞而非成人红细胞,并且能与胎儿和成人的血小板及单核细胞结合。在本研究中,我们对FA6 - 152在人血小板以及不同成熟阶段红系谱系细胞上识别的抗原进行了特性分析。FA6 - 152从碘化和高碘酸盐/硼氢化钠3H4表面标记的血小板中沉淀出一种抗胰凝乳蛋白酶的88 kDa唾液糖蛋白,它对应于糖蛋白IV,即血小板凝血酶敏感蛋白(TSP)受体。经神经氨酸酶处理后,观察到表观分子量从88 kDa转变为85 kDa。斯卡查德分析表明,125I - FA6 - 152以高亲和力饱和结合到一类单一的血小板结合位点(解离常数Kd为6.4±0.6 nM)。每个血小板结合的FA� - 152 IgG分子数为25,400±8,800(n = 4),并且在血小板经凝血酶激活后没有变化。在低剂量α - 凝血酶(0.025单位)时,FA6 - 152抑制血小板聚集以及内源性TSP与血小板表面的结合。对骨髓细胞以及体外红系爆式集落形成单位(BFU - E)和红系集落形成单位(CFU - E)培养物进行免疫荧光标记显示,FA6 - 152抗原是红系分化的一个非常早期的标志物,并且其表达在成熟过程中下降。对胎儿成红细胞和胎儿成熟红细胞上的FA6 - 152抗原进行免疫化学鉴定,发现一种78 kDa糖蛋白迁移至血型糖蛋白A二聚体前方。该抗原在成人成熟红细胞中不存在,但在人红白血病(HEL)细胞中也被检测到,在那里FA6 - 152沉淀出两条分子量为85和88 kDa的条带。我们的数据证实存在一种先前未被鉴定的78 kDa成红细胞细胞表面糖蛋白,其表达在红系分化过程中受到发育调控,并且在免疫上与88 kDa血小板TSP受体相关。